2022 at a Glance Chairman’s Letter CEO’s Report Key Milestones Pipeline Review ESG Financial Reports 41 Kazia Theraputics Limited Annual Report 2022 STATEMENT OF CHANGES IN EQUITY For the year ended 30 June 2022 Contributed equity Other contributed equity Foreign currency translation reserve Share based payments reserve Accumulated losses Total equity Consolidated $ $ $ $ $ $ Balance at 1 July 2020 48,781,214 464,000 (455,188) 1,521,111 (36,185,557) 14,125,580 Loss after income tax benefit for the year - - - - (8,421,960) (8,421,960) Other comprehensive income for the year, net of tax - - 1,868 - - 1,868 Total comprehensive income for the year - - 1,868 - (8,421,960) (8,420,092) Shares issued (note 18) 32,908,949 - - - - 32,908,949 Share issue costs (note 18) (1,673,388) - - - - (1,673,388) Transactions with owners in their capacity as owners: Issue of shares on exercise of options 273,287 - - (80,353) 80,353 273,287 Share based payment (note 33) - - - 636,383 - 636,383 Expired options - - - (323,255) 323,255 - Balance at 30 June 2021 80,290,062 464,000 (453,320) 1,753,886 (44,203,909) 37,850,719 The above statement of changes in equity should be read in conjunction with the accompanying notes Our Collaborators
RkJQdWJsaXNoZXIy MjE2NDg3